8-Azaspiro[4.5]decan-2-ylmethyl acetate is primarily utilized in the field of organic synthesis and pharmaceutical research. It serves as a key intermediate in the development of various bioactive compounds, particularly those targeting the central nervous system. Its spirocyclic structure makes it valuable in designing molecules with specific stereochemical properties, which can enhance drug efficacy and selectivity. Additionally, this compound is explored in the synthesis of potential therapeutic agents for neurological disorders, such as anxiety, depression, and cognitive impairments. Its application extends to the creation of novel chemical entities in medicinal chemistry, where it aids in optimizing pharmacokinetic and pharmacodynamic profiles.